Nl-Fr

View abstract

This abstract is assigned to session Poster Session - On Display Posters nr 300 ... 399
Presentation preference Oral presentation
TitleCyclosporine versus adalimumab added to corticosteroids for Vogt-Koyanagi-Harada disease
PurposeTo compare effectiveness of cyclosporine versus adalimumab added to corticosteroids for the treatment of Vogt-Koyanagi-Harada disease.
MethodsWe randomly assigned 110 patients (27 early-phase and 83 late-phase VKH disease) to receive cyclosporine plus corticosteroids or adalimumab plus corticosteroids in a 1:1 ratio with disease phase as a stratification factor. The primary outcome was the change from baseline in best corrected visual acuity (BCVA) measured as Early Treatment Diabetic Retinopathy Study (ETDRS) score at week 26. The minimal clinically important difference for changes in ETDRS score is -7 letters, which constituted the margin of non-inferiority for cyclosporine plus corticosteroids. We analyzed the data from early and late-phase VKH patients as two separate studies.
ResultsIn early-phase VKH disease, the primary outcome was 12.1 letters (95% CI, 8.5 to 15.7) in the cyclosporine-corticosteroids group and 13.0 letters (95% CI, 9.1 to 16.9) in the adalimumab-corticosteroids group (difference, -0.8; 95% CI, -6.1 to 4.5). In late-phase VKH disease, the primary outcome was 7.2 letters (95% CI, 3.4 to 11.0) in the cyclosporine-corticosteroids group and 1.5 letters (95% CI, -2.3 to 5.3) in the adalimumab-corticosteroids (difference, 5.7; 95% CI, 0.2 to 11.2).
ConclusionCyclosporine plus corticosteroids was non-inferior to adalimumab plus corticosteroids on the basis of primary results of visual acuity at 26 weeks, regardless of early or late phase.
Conflict of interestNo
Authors 1
Last nameZHONG
Initials of first name(s)Z
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 2
Last nameDai
Initials of first name(s)L
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 3
Last nameWu
Initials of first name(s)Q
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 4
Last nameGao
Initials of first name(s)Y
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 5
Last namePu
Initials of first name(s)Y
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 6
Last nameSu
Initials of first name(s)G
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 7
Last nameLu
Initials of first name(s)X
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 8
Last nameZhang
Initials of first name(s)F
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 9
Last nameTang
Initials of first name(s)C
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina
Authors 10
Last nameYang
Initials of first name(s)P
DepartmentThe First Affiliated Hospital of Chongqing Medical University
CityChongqing
CountryChina